Safran SA (OTCMKTS:SAFRY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company.
A number of brokerages have commented on SAFRY. Citigroup downgraded shares of Safran from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 10th. Kepler Capital Markets upgraded shares of Safran from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 28th. Barclays restated an “overweight” rating on shares of Safran in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Safran in a research note on Thursday, May 22nd.
Check Out Our Latest Research Report on SAFRY
Safran Price Performance
Safran Increases Dividend
The firm also recently disclosed a dividend, which was paid on Monday, June 23rd. Stockholders of record on Thursday, May 29th were paid a dividend of $0.6108 per share. The ex-dividend date of this dividend was Wednesday, May 28th. This is an increase from Safran’s previous dividend of $0.59. This represents a dividend yield of 0.82%.
About Safran
Safran SA, together with its subsidiaries, engages in the aerospace and defense businesses worldwide. The company operates through three segments: Aerospace Propulsion; Aircraft Equipment, Defense and Aerosystems; and Aircraft Interiors. The Aerospace Propulsion segment designs, develops, produces, and markets propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, satellites, and drones; and offers maintenance, repair, and overhaul (MRO) services, as well as sells spare parts.
Further Reading
- Five stocks we like better than Safran
- What Are the FAANG Stocks and Are They Good Investments?
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- How to Invest in Insurance Companies: A Guide
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for Safran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safran and related companies with MarketBeat.com's FREE daily email newsletter.